Gedeon Richter Publishes Country-by-Country Tax Data
Pharmaceutical company Gedeon Richter Plc. has released its 2025 country-by-country reporting. The report includes comprehensive data on the company's revenues, profits, and employee numbers across various nations.
Gedeon Richter Plc., the Hungarian pharmaceutical firm, has disclosed its detailed country-by-country report for the 2025 financial year. This report provides transparency into the company's financial operations and tax obligations across its various operating jurisdictions in Europe and Vietnam.
The reporting covers Gedeon Richter's revenues, profits before tax, taxes paid and accrued, and employee numbers for each reporting jurisdiction. Hungary, the company's home country, stands as the most significant operational base in terms of revenue and profit, generating a substantial portion of the group's overall results. Germany also emerges as a notable market by revenue.
The company's report reveals regional variations in financial performance and taxation. Certain countries, such as Ireland and the Netherlands, reported losses before tax, while others, like Russia and Poland, show stronger profitability relative to their revenue figures. These numbers reflect local market conditions, business models, and investment activities.
The country-by-country reporting is part of Gedeon Richter's efforts to enhance transparency and comply with EU tax legislation requirements. The company conducts diverse business activities, including research and development, manufacturing, sales, marketing, and administrative services through its various subsidiaries. The report offers stakeholders a clearer understanding of the company's global tax footprint.